Nephros Inc (NEPH) 0.5000 $NEPH Nephros Reports Second

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nephros Inc (NEPH) 0.5000 $NEPH

Nephros Reports Second Quarter 2016 Financial Results
ACCESSWIRE - Mon Aug 08, 6:42AM CDT
RIVER EDGE, NJ / ACCESSWIRE / August 8, 2016 / Nephros, Inc. (OTCQB: NEPH), (the "Company" a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF" system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, today announced financial results for the three months ended June 30, 2016.

Nephros Announces Closing of $1.2 Million Note and Warrant Offering
ACCESSWIRE - Thu Jun 09, 3:30PM CDT
RIVER EDGE, NJ / ACCESSWIRE / June 9, 2016 / Nephros, Inc. (OTCQB: NEPH) (the "Company", a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today that it has completed a private placement of unsecured promissory notes and warrants to purchase the Company's common stock resulting in total gross proceeds to the Company of approximately $1.2 million.

Nephros Announces Distribution Agreement with CS Medical, LLC
ACCESSWIRE - Mon May 23, 6:30AM CDT
RIVER EDGE, NJ / ACCESSWIRE / May 23, 2016 / Nephros, Inc. (OTCQB: NEPH), (the "Company" a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has signed a distribution agreement with CS Medical, LLC, a leader in developing, manufacturing, and marketing medical devices designed to provide high-level disinfection of ultrasound Trans-Esophageal Echocardiogram ("TEE" probes.

Nephros Announces Submission of Special 510(k) Application to the FDA for the EndoPur(TM) Ultrafilter
ACCESSWIRE - Thu Apr 21, 6:30AM CDT
RIVER EDGE, NJ / ACCESSWIRE / April 21, 2016 / Nephros, Inc. (OTCQB: NEPH), (the "Company" a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF" system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today that it has submitted a Special 510(k) application to the U.S. Food and Drug Administration (FDA) for its EndoPur(TM) ultrafilter designed to provide hemodialysis quality water.

Nephros Receives FDA 510(k) Clearance of S100 Point of Use Filter
ACCESSWIRE - Thu Apr 14, 6:30AM CDT
RIVER EDGE, NJ / ACCESSWIRE / April 14, 2016 / Nephros, Inc. (OTCQB:NEPH), (the "Company" a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF" system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA" to market its S100 Point of Use filter designed to filter Environmental Protection Agency ("EPA" quality drinking water to retain waterborne bacteria to assist in infection control.

SeeThruEquity Issues Update on Nephros, Inc. (OTCQB: NEPH)
ACCESSWIRE - Wed Apr 06, 8:01AM CDT
NEW YORK, NY / ACCESSWIRE / April 6, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update note on Nephros, Inc. (OTCQB: NEPH).

Nephros publishes observational trial of DSU-D in Hospital-Based Dialysis Facility in Nephrology and Dialysis
M2 - Tue Jan 19, 4:50AM CST
Medical device company Nephros (OTCBB:NEPH) said on Monday that data about its DSU-D ultrafilter was published online in Case Reports in Nephrology and Dialysis.

SeeThruEquity Issues Company Update On Nephros, Inc. (OTCQB: NEPH)
ACCESSWIRE - Mon Nov 30, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / November 30, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company update on Nephros, Inc. (OTCQB: NEPH).

Nephros to Present at the LD Micro Main Event
ACCESSWIRE - Tue Nov 24, 8:20AM CST
LOS ANGELES, CA / ACCESSWIRE / November 24, 2015 / Nephros (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, today announced that it will be presenting at the 8th annual LD Micro Main Event on Tuesday, December 1st at 3 PM PST / 6 PM EST. President and CEO and Nephros, Daron Evans, will be giving the presentation and meeting with investors.

Nephros submits S100 Ultrafilter to US FDA for control of infection in medical facilities
M2 - Wed Oct 28, 6:08AM CDT
Medical device company Nephros (OTCBB:NEPH) said on Tuesday that it has submitted the S100 Point of Use filter designed to filter Environmental Protection Agency (EPA) quality drinking water to retain waterborne bacteria to assist in infection control for US Food and Drug Administration (FDA) 510(k) clearance.

Nephros hires Moshe Pinto to board
M2 - Tue Aug 18, 6:04AM CDT
Medical device company Nephros (OTCBB:NEPH) revealed on Monday that Moshe Pinto has been appointed to its board of directors.

Nephros, Inc. Enters Into Purchase Agreement with Lincoln Park Capital Fund, LLC
BusinessWire - Mon Jul 27, 6:30AM CDT
Nephros, Inc. (OTCBB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF" system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC ("LPC", a Chicago-based institutional investor. Under the terms of the purchase agreement, over a 36-month term, Nephros will have the right and the sole discretion to sell to LPC up to $10 million worth of shares of Nephros common stock in amounts as set forth in the agreement. Nephros will control the timing and amount of any future investment and LPC will be obligated to make purchases in accordance with the agreement.

SeeThruEquity Initiates Coverage on Nephros, Inc. (OTCBB: NEPH) with Price Target of $1.65
ACCESSWIRE - Thu Jun 04, 7:57AM CDT
NEW YORK, NY / ACCESSWIRE / June 4, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Nephros, Inc. (OTCQB: NEPH) with Price Target of $1.65.

Nephros posts higher net operating loss of USD806,000 for Q1 2015
M2 - Mon May 18, 5:17AM CDT
Medical device company Nephros (OTCBB:NEPH) disclosed on Friday that it recorded a net operating loss of USD806,000 for the three months ended 31 March 2015.

Nephros expects USD1.2m from private placement of common shares
M2 - Wed May 13, 6:57AM CDT
Medical device company Nephros (OTCBB:NEPH) reported on Tuesday the launch of definitive agreements for the sale of about USD1.2m of its common stock.

Nephros hires Malcolm Persen to board
M2 - Mon May 11, 7:31AM CDT
Medical device company Nephros (OTCBB:NEPH) disclosed on Friday the addition appointment of Malcolm Persen to its board of directors, including chair of the Audit Committee.

Nephros signs HydraGuard military filter licensing agreement with CamelBak
M2 - Thu May 07, 5:15AM CDT
Medical device company Nephros (OTCBB:NEPH) reported on Wednesday that it has granted the exclusive license to its HydraGuard military filter to CamelBak for an undisclosed value.

Nephros Provides Corporate Update
BusinessWire - Mon Dec 08, 3:49PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, today provided an update on its operations and strategy.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
s?page=2">More News Articles